首页 | 本学科首页   官方微博 | 高级检索  
     

从药品不良反应信息通报品种看药品风险管理(六)
引用本文:陈易新,田春华. 从药品不良反应信息通报品种看药品风险管理(六)[J]. 中国药物警戒, 2008, 5(4): 201-204
作者姓名:陈易新  田春华
作者单位:国家食品药品监督管理局药品评价中心,北京,100045
摘    要:目的以我国药品不良反应信息通报制度建立为背景,结合药品不良反应监测工作的阶段特点,重点分析被通报品种的监管历程,并从具体实施的行政举措展示药品风险管理的效应。方法以被通报的具体品种为线索,重点采用文献调研、系统分析的方法进行论述性阐述。结果对被通报品种在不同阶段所采取的风险管理措施与当时社会、政策以及工作背景密切相关。结论药品风险管理是一个复杂、艰巨和渐进性的工作。

关 键 词:药品  不良反应  信息通报  风险管理

Adverse Drug Reaction Information Bulletin and Risk Management on Drugs(6)
CHEN Yi-xin,TIAN Chun-huaCenter for Drug Reevaluation,SFDA. Adverse Drug Reaction Information Bulletin and Risk Management on Drugs(6)[J]. Chinese JOurnal of Pharmacovigilance, 2008, 5(4): 201-204
Authors:CHEN Yi-xin  TIAN Chun-huaCenter for Drug Reevaluation  SFDA
Affiliation:(Center for Drug Reevaluation,SFDA,Beijing 100045;China)
Abstract:Objective Combining with the characteristics of the work of ADR monitoring in different historic period,this article analyzes the process of surveillance on the background of establishing the system of ADR Information Bulletin.And it shows the results of risk management by specific admin-istrative measures on every drug.Methods The drugs in the Information Bulletin are as the clue,the article does to discuss the issued drugs and risk management by literature review and systematic analysis.Results The measures of risk management on issued drugs are highly relative with the society,policy and monitoring background at that time.Conclusion Drugs risk management is a complicated and tough protracted work.
Keywords:drugs  adverse reaction  information bulletin  risk management
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号